z-logo
open-access-imgOpen Access
Role of Imaging in the Evaluation of Patients at Risk for Sudden Cardiac Death
Author(s) -
Sherif F. Nagueh,
William A. Zoghbi
Publication year - 2015
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2015.04.006
Subject(s) - catecholaminergic polymorphic ventricular tachycardia , brugada syndrome , sudden cardiac death , medicine , cardiology , hypertrophic cardiomyopathy , sudden death , risk stratification , cardiomyopathy , ventricular tachycardia , long qt syndrome , genetic testing , qt interval , heart failure , ryanodine receptor 2 , ryanodine receptor , calcium
Several monogenic cardiac disorders are associated with sudden cardiac death. These include primary electrophysiological disorders (long QT, short QT, Brugada, and catecholaminergic ventricular tachycardia syndromes) and cardiomyopathies, including hypertrophic and dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy. This review presents the genotype-phenotype relations in these diseases. In addition to establishing a diagnosis, imaging can play an important role in identifying the pathophysiological abnormalities and hence the potential to guide therapy in some patients. Furthermore, imaging findings in some patients add incremental prognostic information for risk stratification of sudden cardiac death. Finally, along with genetic testing, imaging is important for screening and, in some cases, can identify subjects with positive mutations who have not yet developed the classical phenotype.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom